PF-05089771 + PF-05089771 + PF-05089771 + Ibuprofen
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Postoperative Dental Pain
Conditions
Postoperative Dental Pain
Trial Timeline
Dec 12, 2011 → Jun 25, 2012
NCT ID
NCT01529346About PF-05089771 + PF-05089771 + PF-05089771 + Ibuprofen
PF-05089771 + PF-05089771 + PF-05089771 + Ibuprofen is a phase 2 stage product being developed by Pfizer for Postoperative Dental Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT01529346. Target conditions include Postoperative Dental Pain.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01529346 | Phase 2 | Completed |
Competing Products
20 competing products in Postoperative Dental Pain